E-labdoc.roche.com

SAFETY DATA SHEET according to Regulation (EC) No. 1907/2006 Ampicillin, 50g
1. Identification of the substance/mixture and of the company/undertaking
1.1 Product identifier
1.2 Relevant identified uses of the substance or mixture and uses advised against
1.3 Details of the supplier of the safety data sheet
: +49(0)621-759-2012 +49(0)621-759-4848+49(0)8856-60- 2. Hazards identification
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008)
Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008. Classification (67/548/EEC, 1999/45/EC)
Not a hazardous substance or mixture according to EC-directives 67/548/EEC or 1999/45/EC. 2.2 Label elements
Labelling (REGULATION (EC) No 1272/2008)
Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008. 2.3 Other hazards
3. Composition/information on ingredients
3.1 Substances
SAFETY DATA SHEET according to Regulation (EC) No. 1907/2006 Ampicillin, 50g
(aminophenylacetamido )-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate : No dangerous ingredients according to Regulation (EC) No. 4. First aid measures
4.1 Description of first aid measures
: If unconscious place in recovery position and seek medical advice. If symptoms persist, call a physician. : Immediately flush eye(s) with plenty of water. Remove contact lenses. Protect unharmed eye. If eye irritation persists, consult a specialist. Do not give milk or alcoholic beverages. Never give anything by mouth to an unconscious person. If symptoms persist, call a physician. Rinse mouth with water. 4.2 Most important symptoms and effects, both acute and delayed
4.3 Indication of any immediate medical attention and special treatment needed
: The first aid procedure should be established in consultation with the doctor responsible for industrial medicine. 5. Fire-fighting measures
5.1 Extinguishing media
: Use extinguishing measures that are appropriate to local SAFETY DATA SHEET according to Regulation (EC) No. 1907/2006 Ampicillin, 50g
circumstances and the surrounding environment. 5.2 Special hazards arising from the substance or mixture
5.3 Advice for firefighters
: Wear self contained breathing apparatus for fire fighting if : Standard procedure for chemical fires. Use extinguishing measures that are appropriate to local circumstances and the surrounding environment. 6. Accidental release measures
6.1 Personal precautions, protective equipment and emergency procedures
6.2 Environmental precautions
: Local authorities should be advised if significant spillages 6.3 Methods and materials for containment and cleaning up
: Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed containers for disposal. 6.4 Reference to other sections
Treat recovered material as described in the section "Disposal considerations". 7. Handling and storage
7.1 Precautions for safe handling
: For personal protection see section 8. Smoking, eating and drinking should be prohibited in the application area. : Provide appropriate exhaust ventilation at places where dust 7.2 Conditions for safe storage, including any incompatibilities
: Electrical installations / working materials must comply with : No materials to be especially mentioned. SAFETY DATA SHEET according to Regulation (EC) No. 1907/2006 Ampicillin, 50g
: No decomposition if stored and applied as directed. 7.3 Specific end uses
8. Exposure controls/personal protection
8.1 Control parameters
Contains no substances with occupational exposure limit values. 8.2 Exposure controls
Personal protective equipment
: No personal respiratory protective equipment normally Environmental exposure controls
: Local authorities should be advised if significant spillages 9. Physical and chemical properties
9.1 Information on basic physical and chemical properties
: ca. 9, Concentration: 100,00 g/l, 20 °C SAFETY DATA SHEET according to Regulation (EC) No. 1907/2006 Ampicillin, 50g
: The substance or mixture is not classified as oxidizing. 9.2 Other information
10. Stability and reactivity
10.1 Reactivity
No dangerous reaction known under conditions of normal use. 10.2 Chemical stability
10.3 Possibility of hazardous reactions
: Further information: No hazards to be specially mentioned. 10.4 Conditions to avoid
10.5 Incompatible materials
10.6 Hazardous decomposition products
Carbon dioxide (CO2), carbon monoxide (CO), oxides of nitrogen (NOx), dense black smoke. 11. Toxicological information
11.1 Information on toxicological effects
SAFETY DATA SHEET according to Regulation (EC) No. 1907/2006 Ampicillin, 50g
: Assessment: The substance or mixture is not classified as specific target organ toxicant, single exposure. : Assessment: The substance or mixture is not classified as specific target organ toxicant, repeated exposure. 12. Ecological information
12.1 Toxicity
Ecotoxicology Assessment
12.2 Persistence and degradability
12.3 Bioaccumulative potential
12.4 Mobility in soil
SAFETY DATA SHEET according to Regulation (EC) No. 1907/2006 Ampicillin, 50g
environmental compartments Environmental fate and 12.5 Results of PBT and vPvB assessment
: This substance is not considered to be persistent, bioaccumulating nor toxic (PBT)., This substance is not considered to be very persistent nor very bioaccumulating (vPvB). 12.6 Other adverse effects
13. Disposal considerations
13.1 Waste treatment methods
: The product has to be disposed of as laboratory chemical in : Empty containers should be taken to an approved waste handling site for recycling or disposal. 14. Transport information
14.1 UN number
Not dangerous goods
IMDG
Not dangerous goods
IATA
14.2 Proper shipping name
Not dangerous goods
IMDG
Not dangerous goods
IATA
14.3 Transport hazard class
SAFETY DATA SHEET according to Regulation (EC) No. 1907/2006 Ampicillin, 50g
Not dangerous goods
IMDG
Not dangerous goods
IATA
14.4 Packing group
Not dangerous goods
IMDG
Not dangerous goods
IATA
14.5 Environmental hazards
Not dangerous goods
IMDG
Not dangerous goods
IATA
14.6 Special precautions for user
Not dangerous goods in the meaning of ADR/RID, ADNR, IMDG-Code, ICAO/IATA-DGR 14.7 Transport in bulk according to Annex II of MARPOL 73/78 and the IBC Code
15. Regulatory information
15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture
Inorganic substances in powdered form: not applicable Inorganic substances in vapour or gaseous form: not applicable Organic Substances: not applicable Carcinogenic substances: not applicable Mutagenic: not applicable Toxic to reproduction: not applicable 15.2 Chemical Safety Assessment
A Chemical Safety Assessment is not required for this substance when it is used in the specified applications. 16. Other information
Further information
SAFETY DATA SHEET according to Regulation (EC) No. 1907/2006 Ampicillin, 50g
The information provided in this Safety Data Sheet is correct to the best of our knowledge, information and belief at the date of its publication. The information given is designed only as a guidance for safe handling, use, processing, storage, transportation, disposal and release and is not to be considered a warranty or quality specification. The information relates only to the specific material designated and may not be valid for such material used in combination with any other materials or in any process, unless specified in the text.

Source: http://e-labdoc.roche.com/LFR_PublicDocs/sds/en/10835269001.pdf

hameln.co.uk

PACKAGE LEAFLET: INFORMATION FOR THE USER ThySat® 65 mg tablets ThySat should only be taken when there is a risk of exposure to nuclear STOP radiation. ThySat contains potassium iodide which, when taken at the correct dosage, saturates your thyroid gland with iodine and blocks it from absorbing radioactive iodine helping to prevent thyroid cancer. Read all of this leaflet careful

Ministère public

MÉDIATION PÉNALE ET PROCÉDURE ACCÉLÉRÉE PARADIGMES D’UN NOUVEAU TYPE D’ACTION DU MINISTERE PUBLIC.1 par Christophe MINCKE assistant de recherche à l’UCL Introduction. La satellisation des missions du Ministère public, tel est le sujetdont nous avons à traiter. Le phénomène de multiplication des tâches decette institution a connu une accélération considérable ces

Copyright © 2010 Find Medical Article